VSee Health, Inc.
$0.24
▼
-5.91%
2026-04-21 10:11:00
www.vseehealth.com
NCM: VSEE
Explore VSee Health, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$11.87 M
Current Price
$0.24
52W High / Low
$2.52 / $0.19
Stock P/E
—
Book Value
$-0.33
Dividend Yield
—
ROCE
-476.79%
ROE
-5.42%
Face Value
—
EPS
$-0.73
Exp Qtr EPS
—
Sector
Healthcare
Industry
Health Information Services
Employees
—
Beta
0.65
Debt / Equity
59.78
Current Ratio
0.52
Quick Ratio
0.51
Forward P/E
—
Price / Sales
0.74
Enterprise Value
$8.88 M
EV / EBITDA
-1.27
EV / Revenue
0.61
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Balance sheet leverage appears manageable.
Cons
- Capital efficiency is modest.
- Current ratio suggests tighter short-term liquidity.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Omnicell, Inc. | $37.8 | 839.18 | $1.72 B | — | 0.34% | 0.17% | $55 / $22.66 | $27.36 |
| 2. | HealthEquity, Inc. | $83.22 | 33.83 | $7.04 B | — | 10.16% | 10.19% | $116.65 / $72.76 | $24.79 |
| 3. | Spok Holdings, Inc. | $11.48 | 14.99 | $237.98 M | 10.89% | 12.85% | 10.55% | $19.31 / $10.81 | $7.1 |
| 4. | So-Young International Inc. | $2.9 | — | $283.61 M | 0% | -4.01% | -13.61% | $6.28 / $0.74 | $2.25 |
| 5. | Certara, Inc. | $6.19 | — | $989.85 M | — | 1.5% | -0.15% | $15.38 / $5.19 | $6.68 |
| 6. | Aclarion, Inc. | $3.55 | — | $7.74 M | — | -54.95% | -1.05% | $12.03 / $2.34 | $15.02 |
| 7. | Healthcare Triangle, Inc. | $2.47 | — | $4.86 M | — | 89.58% | -1.83% | $7,470 / $2.24 | $17.67 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|
| Sales | 3.93 M | 3.98 M | — | 3.86 M | 3.35 M |
| Operating Profit | -3.44 M | -2.06 M | — | -3.11 M | -1.16 M |
| Net Profit | -7.85 M | -0.29 M | — | -5.62 M | -53.92 M |
| EPS in Rs | -0.17 | -0.01 | — | -0.12 | -1.14 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 14.62 M | 10.42 M | 5.77 M | 6.38 M |
| Operating Profit | -9.58 M | -4.68 M | -1.79 M | -1.46 M |
| Net Profit | -14.71 M | -57.7 M | -3.76 M | -0.84 M |
| EPS in Rs | -0.31 | -1.22 | -0.08 | -0.02 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 22.41 M | 19.99 M | 0.81 M | 2.61 M |
| Total Liabilities | 16.96 M | 20.01 M | 5.11 M | 2.61 M |
| Equity | 5.45 M | -0.02 M | -3.97 M | 0.36 M |
| Current Assets | 8.37 M | 3.02 M | 0.8 M | 0.76 M |
| Current Liabilities | 16.24 M | 19.01 M | 5.11 M | 2.61 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -3.45 M | -5.79 M | -0.63 M | -0.83 M |
| Investing CF | -0.03 M | -0.03 M | -0 M | — |
| Financing CF | 8.42 M | 6.02 M | 0.53 M | 0.71 M |
| Free CF | -3.48 M | -5.84 M | -0.64 M | -0.83 M |
| Capex | -0.03 M | -0.06 M | -0 M | — |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 80.74% | -9.59% | — | — |
| Earnings Growth % | -1433.43% | -350% | — | — |
| Profit Margin % | -553.69% | -65.26% | -13.11% | — |
| Operating Margin % | -44.94% | -30.99% | -22.95% | — |
| Gross Margin % | 68.87% | 66.47% | 75.81% | — |
| EBITDA Margin % | -554.19% | -29.4% | -24.9% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.